Showing results (81-90 of 801) with videos related to

Sort By:
Pageof 81
Haematologica|November 1, 1993
The clinical significance of the antiplatelet antibody test based on results for 265 thrombocytopenic patientsA Tosetto, M Ruggeri, C Schiavotto, et al.
Blut|August 1, 1989
Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemiaF Rodeghiero, G Castaman, G Soffiati, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 20, 2010
F8 mRNA studies in haemophilia A patients with different splice site mutationsG Castaman, S H Giacomelli, M E Mancuso, et al.
American Journal of Hematology|November 17, 2006
Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 del C) and the missense mutation C2362F: definite evidence for the non-penetrance of the C2362F mutationG Castaman, K Bertoncello, M Bernardi, et al.
Blood|April 1, 1996
Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domainT Izumi, T Hashiguchi, G Castaman, et al.
British Journal of Haematology|December 19, 1998
No treatment for low-risk thrombocythaemia: results from a prospective studyM Ruggeri, G Finazzi, A Tosetto, et al.
Blut|July 1, 1987
Successful pregnancy in a woman with congenital factor XIII deficiency treated with substitutive therapy. Report of a second caseF Rodeghiero, G C Castaman, E Di Bona, et al.
Blood|November 15, 1989
Heterogeneous phenotypes of platelet and plasma von Willebrand factor in obligatory heterozygotes for severe von Willebrand diseaseP M Mannucci, A Lattuada, G Castaman, et al.
Journal of Thrombosis and Haemostasis : JTH|February 15, 2012
Different bleeding risk in type 2A and 2M von Willebrand disease: a 2-year prospective study in 107 patientsG Castaman, A B Federici, A Tosetto, et al.
British Journal of Haematology|May 3, 2000
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemiaE Di Bona, G Avvisati, G Castaman, et al.
Pageof 81